NEW ZEALAND GAZETTE, No. 112

28 JULY 2005

2708

Datura spp; except for oral use when specified elsewhere in
the Schedule; except in datura stramonium or datura
tatula for smoking or burning
Deferiprone
Dextrorphan
Dicyclomine
Digoxin-specific antibody fragment
Diperodon
Drotrecogin
Duboisia leichhardtii; except when specified elsewhere in
the Schedule
Duboisia myoporides; except when specified elsewhere in
the Schedule
Duloxetine
Efalizumab
Emtricitabine
Enfuvirtide
Eplerenone
Epinastine
Epoetins
Etidocaine
Everolimus
Ezetimibe
Felypressin; except when combined with a local anaesthetic
and when used in practice by a registered dental therapist
Fenofibrate
Fluorides; except when specified elsewhere in the Schedule;
except in parenteral nutrition replacement preparations;
for external use in medicines other than pastes, gels or
powders for cleaning the teeth containing more than
2.5% except when used in practice by a registered dental
therapist; except in medicines containing 1.5 milligrams
or less per litre or per kilogram
Folic acid; for injection
Folinic acid; for injection
Fulvestrant
Gefitinib
Glatiramer acetate
Glyceryl trinitrate; for injection; for transdermal use; except
in medicines containing 100 micrograms or less per litre
or per kilogram
Guaiphenesin; except for oral use in medicines containing
2% or less or 200 milligrams or less
Haemophilus influenzae vaccine; except in oral vaccines for
the prophylaxis of bacterial complications of colds
Homatropine
Human protein C
Hyaluronic acid; in injections or implantations for tissue
augmentation or cosmetic use
Hydroquinone; except in medicines for external use
containing 2% or less
Hylan polymer; in injections or implantations for tissue
augmentation or cosmetic use
Hyoscine; except when specified elsewhere in the Schedule;
except in medicines containing 300 micrograms or less
per litre or per kilogram
Hyoscine butylbromide; except when specified elsewhere in
the Schedule
Hyoscyamine; except when specified elsewhere in
the Schedule; except in medicines containing 300
micrograms or less per litre or per kilogram
Hyoscyamus niger; except when specified elsewhere in
the Schedule; except in medicines containing 300

micrograms or less of total solanaceous alkaloids per
litre or per kilogram
Hypromellose; for injection except in intraocular viscoelastic
products
Ibritumomab tiuxetan
Insulins
Isosorbide dinitrate
Ketotifen; except for ophthalmic use in medicines containing
0.025% or less
Laronidase-rch
Levetiracetam
Levosimendan
Lignocaine; for oral use except in throat lozenges containing
30 milligrams or less per dose form; for ophthalmic use
except when used in practice by a registered optometrist;
for injection except when used in practice as a local
anaesthetic by a nurse whose scope of practice permits
the performance of general nursing functions or by a
registered podiatrist or dental therapist; for external use
in medicines containing more than 10%
Lumiracoxib
Melagatran
Memantine
Methyl mercury; except in medicines containing 300
micrograms of methyl mercury per litre or per kilogram
Mitragyna speciosa
Mitragynine
Nicoumalone
Nitrofurazone
Norelgestromin
Nux vomica
Orlistat; except in medicines containing 120 milligrams or
less per dose form
Oxedrine; in medicines containing more than 30 milligrams
per recommended daily dose
Palonosetron
Pegfilgrastim
Pemetrexed
Piridoxine; in medicines containing more than 200
milligrams per recommended daily dose
Pneumococcal vaccine; except in oral vaccines for the
prophylaxis of bacterial complications of colds
Podophyllotoxin; for internal use; for external use for the
treatment of anogenital warts; for other external use in
medicines containing more than 1%
Podophyllum emodi; for internal use; for external use for the
treatment of anogenital warts; for other external use in
medicines containing more than 20% of podophyllin
Podophyllum peltatum; for internal use; for external use for
the treatment of anogenital warts; for other external use
in medicines containing more than 20% of podophyllin
Polyacrilamide; in injections or implantations for tissue
augmentation or cosmetic use
Polylactic acid; in injections or implantations for tissue
augmentation or cosmetic use
Poractant alfa
Pramocaine
Pregabalin
Pregnenolone
Prilocaine; for injection except when used as a local
anaesthetic by a registered dental therapist; except when
specified elsewhere in the Schedule
Prochlorperazine; except when specified elsewhere in the
Schedule; except when sold for the treatment of nausea